MolNFT v2 · #30466 · DNA
Substitutions at C2' of daunosamine in the anticancer daunorubicin alter its DNA-binding sequence specificity
277D: “Substitutions at C2' of daunosamine in the anticancer daunorubicin alter its DNA-binding sequence specificity”. X-ray diffraction at 1.8. MolNFT v2 #30466 on GenesisL1: 3D structure, binding sites and pockets in GL1X.
- PDB
- 277D
- Type
- DNA
- Length
- 6 nucleotides
- Chains
- 1
- Method
- x-ray diffraction
- Collection
- MolNFT v2 / PDB Bank
- Contract
- 0xd58B01f6C18086e5202cdC5D7Ad3E41790360102
- Owner
- 0xF4e1AA6f26B7DA48EeAD9B24a97927303eeA07b8
- Resolution
- 1.8
Structure
x-ray diffraction · resolution 1.8 · 1 distinct chain.
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A | — | dna | 6 | — | — |
Compared structures
- 277D · Substitutions at C2' of daunosamine in the anticancer daunorubicin alter its DNA-binding… · the same entry in another collection · chain A against A, TM-score 1.00
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Elsewhere: RCSB PDB 277D · PDBe 277D
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.